Top Key-Players To Deepen The Growth Curve For Antibody Testing Market
Rapid diagnosis is crucial, and any delay can not only worsen a patient’s condition but can also
result in unregulated spread of infection, as seen with the COVID-19 pandemic.
The antibody testing market includes an extensive portfolio of products catering to many
indications, such as cardiovascular disorders, autoimmune diseases, and bacterial and viral
infectious diseases. Manufacturers not only offer test kits for various indications, but also
provide choices for various types of antibody test kits, such as serological test kits,
immunoglobulin assay kits, and lateral flow assay kits.
As per Persistence Market Research, the global antibody testing market will experience a
healthy CAGR of 8% during the forecast period of 2020–2030.
Get Sample Copy of this
Key Takeaways from Antibody Testing Market Study
The serological test kit product segment is expected to be the most lucrative segment in the
global antibody testing market by the end of 2030.
By indication, the infectious diseases segment is expected to grow 2.6 times from the
year 2020 to 2030.
In terms of end user, the diagnostic laboratories segment is expected to hold 2/5 market share
of the entire global market value in the antibody testing market.
Due to the COVID-19 outbreak, the infection segment increased from 7% in year-on-year
growth in 2018 to 2019 to nearly 12% in 2020.
Countries such as China, India, and Brazil have the potential to drive the future growth of the
antibody testing market, owing to the growing burden of infectious and chronic diseases such
as diabetes across these regions.
“Growing diseases outbreak due to changing planetary dynamics and rising patient
preference for rapid diagnosis will spur the growth of the antibody testing market over the
coming years,” says a PMR analyst.